# Siegfried Evionnaz SA, Evionnaz, Switzerland – FDA Inspections

Source: https://www.keypedia.com/companies/siegfried-evionnaz-sa/80827909-f3d5-4745-bc93-14f265628c39

> Inspection records and compliance data for Siegfried Evionnaz SA in Evionnaz. 6 FDA inspections on record, 1 Form 483, last inspected March 31, 2023.

---

## Details

- Name: Siegfried Evionnaz SA
- FEI Number: 3002807824
- Business Operations: API MANUFACTURE
- Address Line 1: route du Simplon 36
- City: Evionnaz
- Country Name: Switzerland
- Address: route du Simplon 36, Evionnaz, Switzerland
- Country: Switzerland

## Related Documents

- [483 - Siegfried Evionnaz SA - 2023-03-31](https://www.keypedia.com/records/483/siegfried-evionnaz-sa/43a94a56-ca4a-4b09-affc-46158ba90c8d) — source: FDA, date: March 31, 2023
- FDA Inspection 1201487 - Siegfried Evionnaz SA - 2023-03-31 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 31, 2023
- [FDA Inspection 1201487 - Siegfried Evionnaz SA - 2023-03-31](https://www.keypedia.com/records/fda_inspections/siegfried-evionnaz-sa/ecf03b67-5fa7-4689-aca4-356bdfc3ff96) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 31, 2023
- FDA Inspection 1096573 - Siegfried Evionnaz SA - 2019-06-07 — classification: No Action Indicated (NAI), source: FDA, date: June 7, 2019
- FDA Inspection 1096573 - Siegfried Evionnaz SA - 2019-06-07 — classification: No Action Indicated (NAI), source: FDA, date: June 7, 2019
- FDA Inspection 975506 - Siegfried Evionnaz SA - 2016-03-18 — classification: No Action Indicated (NAI), source: FDA, date: March 18, 2016
- FDA Inspection 975506 - Siegfried Evionnaz SA - 2016-03-18 — classification: No Action Indicated (NAI), source: FDA, date: March 18, 2016
- FDA Inspection 860263 - Siegfried Evionnaz SA - 2013-11-14 — classification: No Action Indicated (NAI), source: FDA, date: November 14, 2013
- [FDA Inspection 745497 - Siegfried Evionnaz SA - 2011-09-02](https://www.keypedia.com/records/fda_inspections/siegfried-evionnaz-sa/374759b0-4d31-4dc4-9f98-0f7c616e25d1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 2, 2011
- FDA Inspection 556154 - Siegfried Evionnaz SA - 2008-11-14 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 14, 2008

## Related Companies

- [Hangzhou Huadong Medicine Group Zhejiang Huayi Pharmaceutical Co., LTD.](https://www.keypedia.com/companies/hangzhou-huadong-medicine-group-zhejiang-huayi-pharmaceutical-co-ltd/4fcabfd2-d6e5-41ab-a543-fd9b939f8430)
- [Cambrex Charles City, Inc.](https://www.keypedia.com/companies/cambrex-charles-city-inc/b14d342b-e5ae-4df6-ad7a-39cd62dfb9c6)
- [Dottikon Exclusive Synthesis AG](https://www.keypedia.com/companies/dottikon-exclusive-synthesis-ag/db7bdf8b-bd88-416f-94f2-62f946e90074)
- [Cosma SPA](https://www.keypedia.com/companies/cosma-spa/14f96eaf-912e-4eed-af27-43ec40d9b7b7)
- [Erregierre S.p.A.](https://www.keypedia.com/companies/erregierre-spa/b911826f-b82b-46c8-a7cb-68206ff19d2e)
- [AGC Pharma Chemicals Europe, S.L.U.](https://www.keypedia.com/companies/agc-pharma-chemicals-europe-slu/e6912c0d-c34a-4c03-bbc8-e02054d135e5)
- [Hovione PharmaScience Limited](https://www.keypedia.com/companies/hovione-pharmascience-limited/cb368750-5a82-4f5e-b5b8-d7469313f8fd)
- [Xellia (Taizhou) Pharmaceuticals](https://www.keypedia.com/companies/xellia-taizhou-pharmaceuticals/d0debe75-9c46-480f-a6b6-4695ad2bb771)
- [Solara Active Pharma Sciences Limited](https://www.keypedia.com/companies/solara-active-pharma-sciences-limited/acf65b82-5b4f-4ec5-b3c0-56f3eaed2657)
- [BrightGene Fine Chemical Co., Ltd (Tongyuan Road)](https://www.keypedia.com/companies/brightgene-fine-chemical-co-ltd-tongyuan-road/6829d08d-3634-4dd8-9018-1479d16cb615)

## Related Officers

- [Saleem A. Akhtar](https://www.keypedia.com/people/saleem-a-akhtar/1ea49212-bea5-4d43-bd0a-cdede4d3b1cf)
